imatinib mesylate has been researched along with Laryngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Jiromaru, R; Matsuo, M; Nakagawa, T | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Granata, R; Imbimbo, M; Licitra, L; Locati, L; Pala, L | 1 |
2 other study(ies) available for imatinib mesylate and Laryngeal Neoplasms
| Article | Year |
|---|---|
Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report.
Topics: Aged; Cutaneous Fistula; Humans; Imatinib Mesylate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Molecular Targeted Therapy; Pharyngeal Diseases; Postoperative Complications; Receptors, Platelet-Derived Growth Factor; Retrospective Studies; Vascular Endothelial Growth Factor A | 2022 |
Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Humans; Imatinib Mesylate; Laryngeal Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Tomography, X-Ray Computed | 2016 |